Vera Bradley Financials
This page shows Vera Bradley (VRA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Falling sales and margin compression are outrunning cost cuts, leaving the business dependent on inventory reduction to soften cash burn.
Between FY2024 and FY2026, inventory dropped by$49.2M , yet cumulative operating cash flow across FY2025 and FY2026 was still-$24.1M . That means working-capital release is masking a weaker core engine: even while pulling cash out of stock, the company still could not reach cash break-even.
Since FY2024, revenue is down
Free cash flow stayed negative in FY2025 and FY2026 even as capex fell from
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Vera Bradley's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Vera Bradley has an operating margin of -11.8%, meaning the company retains $-12 of operating profit per $100 of revenue. This below-average margin results in a low score of 26/100, suggesting thin profitability after operating expenses. This is down from -9.0% the prior year.
Vera Bradley's revenue declined 15.4% year-over-year, from $318.8M to $269.7M. This contraction results in a growth score of 7/100.
Vera Bradley has a moderate D/E ratio of 0.73. This balance of debt and equity financing earns a leverage score of 53/100.
With a current ratio of 2.48, Vera Bradley holds $2.48 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 69/100.
While Vera Bradley generated -$10.0M in operating cash flow, capex of $3.3M consumed most of it, leaving -$13.3M in free cash flow. This results in a low score of 23/100, reflecting heavy capital investment rather than weak cash generation.
Vera Bradley generates a -37.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 21/100. This is up from -42.6% the prior year.
Vera Bradley scores 2.89, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Vera Bradley passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Vera Bradley generates $0.21 in operating cash flow (-$10.0M OCF vs -$47.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Vera Bradley earns $-69.1 in operating income for every $1 of interest expense (-$31.9M vs $462K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Vera Bradley generated $269.7M in revenue in fiscal year 2026. This represents a decrease of 15.4% from the prior year.
Vera Bradley's EBITDA was -$24.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.2% from the prior year.
Vera Bradley reported -$47.8M in net income in fiscal year 2026. This represents an increase of 23.2% from the prior year.
Vera Bradley earned $-1.71 per diluted share (EPS) in fiscal year 2026. This represents an increase of 20.5% from the prior year.
Cash & Balance Sheet
Vera Bradley generated -$13.3M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 45.8% from the prior year.
Vera Bradley held $12.5M in cash against $0 in long-term debt as of fiscal year 2026.
Vera Bradley had 28M shares outstanding in fiscal year 2026. This represents an increase of 1.0% from the prior year.
Margins & Returns
Vera Bradley's gross margin was 46.4% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 3.4 percentage points from the prior year.
Vera Bradley's operating margin was -11.8% in fiscal year 2026, reflecting core business profitability. This is down 2.8 percentage points from the prior year.
Vera Bradley's net profit margin was -17.7% in fiscal year 2026, showing the share of revenue converted to profit. This is up 1.8 percentage points from the prior year.
Vera Bradley's ROE was -37.6% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 5.0 percentage points from the prior year.
Capital Allocation
Vera Bradley spent $0 on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.
Vera Bradley invested $3.3M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 68.3% from the prior year.
VRA Income Statement
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $55.7M-10.5% | $62.3M-12.1% | $70.9M+37.2% | $51.7M-40.2% | $86.4M+22.5% | $70.5M-25.0% | $94.0M+38.3% | $67.9M |
| Cost of Revenue | $26.9M-25.5% | $36.1M+2.0% | $35.4M+22.4% | $28.9M | N/A | $32.1M-32.2% | $47.3M+39.5% | $33.9M |
| Gross Profit | $28.8M+10.1% | $26.2M-26.2% | $35.5M+55.9% | $22.8M-42.6% | $39.7M+3.3% | $38.4M-17.8% | $46.7M+37.2% | $34.0M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $34.1M-11.7% | $38.7M-4.4% | $40.4M-0.9% | $40.8M | N/A | $46.7M+5.1% | $44.4M-1.4% | $45.1M |
| Operating Income | -$4.6M+61.8% | -$12.2M-165.1% | -$4.6M+74.3% | -$17.9M | N/A | -$8.2M-440.7% | $2.4M+122.5% | -$10.6M |
| Interest Expense | -$65K+51.9% | -$135K-0.7% | -$134K-3450.0% | $4K | N/A | $15K-93.2% | $219K | N/A |
| Income Tax | $112K+100.0% | $56K+429.4% | -$17K-104.2% | $407K | N/A | $5.2M+205.7% | -$4.9M-93.3% | -$2.5M |
| Net Income | -$4.8M+61.0% | -$12.4M-164.7% | -$4.7M+86.0% | -$33.5M+28.8% | -$47.0M-267.0% | -$12.8M-324.3% | $5.7M+170.3% | -$8.1M |
| EPS (Diluted) | $-0.17+61.4% | $-0.44-158.8% | $-0.17+85.8% | $-1.20+29.0% | $-1.69-267.4% | $-0.46-342.1% | $0.19+173.1% | $-0.26 |
VRA Balance Sheet
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $219.2M-10.0% | $243.7M-8.5% | $266.2M-0.7% | $267.9M-12.6% | $306.7M-14.6% | $359.0M-5.3% | $379.2M+2.9% | $368.7M |
| Current Assets | $111.5M-8.9% | $122.3M-12.9% | $140.5M+3.6% | $135.5M-17.8% | $164.9M-10.8% | $184.8M-17.3% | $223.5M+2.3% | $218.4M |
| Cash & Equivalents | $12.5M+16.6% | $10.7M-29.3% | $15.2M+34.6% | $11.3M-60.6% | $28.6M+108.8% | $13.7M-68.9% | $44.1M-20.0% | $55.2M |
| Inventory | $73.0M-12.0% | $82.9M-14.2% | $96.7M-2.5% | $99.2M+8.4% | $91.4M-30.4% | $131.3M-1.3% | $133.0M+6.3% | $125.2M |
| Accounts Receivable | $17.3M-8.8% | $19.0M+11.7% | $17.0M+16.4% | $14.6M+5.7% | $13.8M-43.1% | $24.3M-3.4% | $25.1M+40.6% | $17.9M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $92.2M-20.3% | $115.6M-8.0% | $125.7M+3.1% | $121.9M-4.6% | $127.7M-4.5% | $133.8M-2.1% | $136.7M+11.3% | $122.8M |
| Current Liabilities | $45.0M-7.5% | $48.6M-15.8% | $57.7M-3.0% | $59.5M+2.6% | $58.0M-3.0% | $59.8M-23.7% | $78.3M+24.3% | $63.0M |
| Long-Term Debt | N/A | $10.0M0.0% | $10.0M | N/A | $0 | N/A | N/A | N/A |
| Total Equity | $127.0M-0.8% | $128.1M-8.8% | $140.5M-3.8% | $146.0M-18.4% | $179.0M-20.5% | $225.2M-7.1% | $242.5M-1.4% | $245.9M |
| Retained Earnings | $167.6M-1.3% | $169.8M-6.8% | $182.1M-2.5% | $186.8M-15.2% | $220.3M-17.6% | $267.3M-4.6% | $280.1M+2.1% | $274.3M |
VRA Cash Flow Statement
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5.3M-31.2% | -$4.0M+25.8% | -$5.4M+69.9% | -$17.9M-182.7% | $21.7M+195.8% | -$22.6M-1717.0% | $1.4M+109.6% | -$14.5M |
| Capital Expenditures | $333K-26.3% | $452K-39.1% | $742K-60.3% | $1.9M-56.7% | $4.3M+80.0% | $2.4M-13.8% | $2.8M+222.8% | $863K |
| Free Cash Flow | -$5.6M-25.3% | -$4.5M+27.4% | -$6.1M+69.0% | -$19.8M-214.1% | $17.3M+169.3% | -$25.0M-1701.7% | -$1.4M+91.0% | -$15.4M |
| Investing Cash Flow | -$333K+26.3% | -$452K+25.7% | -$608K+37.2% | -$968K+77.6% | -$4.3M-80.0% | -$2.4M+13.8% | -$2.8M-222.8% | -$863K |
| Financing Cash Flow | -$412K-2323.5% | -$17K-100.2% | $10.0M+5931.0% | -$171K+73.4% | -$644K+88.3% | -$5.5M+42.9% | -$9.7M-44.0% | -$6.7M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | $0 | $0 | $0-100.0% | $585K-88.9% | $5.3M-44.6% | $9.5M+50.4% | $6.3M |
VRA Financial Ratios
| Metric | Q2'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.8%+9.7pp | 42.1%-8.0pp | 50.1%+6.0pp | 44.1%-1.9pp | 45.9%-8.6pp | 54.5%+4.8pp | 49.7%-0.4pp | 50.1% |
| Operating Margin | -8.3%+11.2pp | -19.6%-13.1pp | -6.5%+28.1pp | -34.6% | N/A | -11.6%-14.1pp | 2.5%+18.2pp | -15.6% |
| Net Margin | -8.7%+11.2pp | -19.9%-13.3pp | -6.6%+58.2pp | -64.8%-10.4pp | -54.4%-36.2pp | -18.2%-24.2pp | 6.1%+18.0pp | -11.9% |
| Return on Equity | -3.8%+5.9pp | -9.7%-6.3pp | -3.3%+19.6pp | -22.9%+3.3pp | -26.3%-20.6pp | -5.7%-8.0pp | 2.4%+5.7pp | -3.3% |
| Return on Assets | -2.2%+2.9pp | -5.1%-3.3pp | -1.8%+10.7pp | -12.5%+2.8pp | -15.3%-11.8pp | -3.6%-5.1pp | 1.5%+3.7pp | -2.2% |
| Current Ratio | 2.48-0.0 | 2.52+0.1 | 2.43+0.2 | 2.28-0.6 | 2.84-0.2 | 3.09+0.2 | 2.85-0.6 | 3.47 |
| Debt-to-Equity | 0.73+0.6 | 0.080.0 | 0.07-0.8 | 0.83+0.8 | 0.00-0.6 | 0.59+0.0 | 0.56+0.1 | 0.50 |
| FCF Margin | -10.0%-2.9pp | -7.2%+1.5pp | -8.7%+29.6pp | -38.3%-58.3pp | 20.1%+55.5pp | -35.5%-34.0pp | -1.5%+21.2pp | -22.7% |
Similar Companies
Frequently Asked Questions
What is Vera Bradley's annual revenue?
Vera Bradley (VRA) reported $269.7M in total revenue for fiscal year 2026. This represents a -15.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Vera Bradley's revenue growing?
Vera Bradley (VRA) revenue declined by 15.4% year-over-year, from $318.8M to $269.7M in fiscal year 2026.
Is Vera Bradley profitable?
No, Vera Bradley (VRA) reported a net income of -$47.8M in fiscal year 2026, with a net profit margin of -17.7%.
What is Vera Bradley's EBITDA?
Vera Bradley (VRA) had EBITDA of -$24.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Vera Bradley's gross margin?
Vera Bradley (VRA) had a gross margin of 46.4% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Vera Bradley's operating margin?
Vera Bradley (VRA) had an operating margin of -11.8% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Vera Bradley's net profit margin?
Vera Bradley (VRA) had a net profit margin of -17.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Vera Bradley's return on equity (ROE)?
Vera Bradley (VRA) has a return on equity of -37.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Vera Bradley's free cash flow?
Vera Bradley (VRA) generated -$13.3M in free cash flow during fiscal year 2026. This represents a 45.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Vera Bradley's operating cash flow?
Vera Bradley (VRA) generated -$10.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Vera Bradley's total assets?
Vera Bradley (VRA) had $219.2M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Vera Bradley's capital expenditures?
Vera Bradley (VRA) invested $3.3M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Vera Bradley's current ratio?
Vera Bradley (VRA) had a current ratio of 2.48 as of fiscal year 2026, which is generally considered healthy.
What is Vera Bradley's debt-to-equity ratio?
Vera Bradley (VRA) had a debt-to-equity ratio of 0.73 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Vera Bradley's return on assets (ROA)?
Vera Bradley (VRA) had a return on assets of -21.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Vera Bradley's cash runway?
Based on fiscal year 2026 data, Vera Bradley (VRA) had $12.5M in cash against an annual operating cash burn of $10.0M. This gives an estimated cash runway of approximately 15 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Vera Bradley's Altman Z-Score?
Vera Bradley (VRA) has an Altman Z-Score of 2.89, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Vera Bradley's Piotroski F-Score?
Vera Bradley (VRA) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Vera Bradley's earnings high quality?
Vera Bradley (VRA) has an earnings quality ratio of 0.21x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Vera Bradley cover its interest payments?
Vera Bradley (VRA) has an interest coverage ratio of -69.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Vera Bradley?
Vera Bradley (VRA) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.